Iran unveils its second homegrown coronavirus vaccine project, the day before the launch of a vaccination campaign to combat the Middle East’s deadliest COVID-19 outbreak.
“We will start human tests in the coming days, or in a week at the latest,” Massoud Soleimani, a member of Iran’s national vaccine committee, tells journalists in Karaj near Tehran.
The vaccine, dubbed Razi Cov Pars, was developed at the Razi Vaccine and Serum Research Institute, which is linked to the agriculture ministry, Soleimani says.
At the start of Phase 1 of the clinical trials, “13 volunteers between the ages of 18 and 55” will receive a shot, he adds.
The unveiling comes the day before the launch Tuesday of a campaign to vaccinate Iran’s 80-million-plus population, starting with the Sputnik V jab, according to Health Minister Saeed Namaki.
The first doses of the Russian vaccine arrived on Thursday in Tehran, with two other shipments expected by February 18 and 28, according to Iranian authorities.
Discover Israel's most beloved poet
She died more than four decades ago, but Leah Goldberg remains a magnetic and enigmatic figure: Israel’s most beloved poet, a powerful woman who lived with her mother and never married, who reinvented herself from the ashes of World War I through her magical writing.
You can screen 'The Five Houses of Leah Goldberg' June 4-11. Join The Times of Israel Community today to support our work and watch this and other outstanding documentary films in our DocuNation series.
I want to see it
I want to see it
Already a member? Sign in to stop seeing this
You're a dedicated reader
We’re really pleased that you’ve read X Times of Israel articles in the past month.
That’s why we started the Times of Israel - to provide discerning readers like you with must-read coverage of Israel and the Jewish world.
So now we have a request. Unlike other news outlets, we haven’t put up a paywall. But as the journalism we do is costly, we invite readers for whom The Times of Israel has become important to help support our work by joining The Times of Israel Community.
For as little as $6 a month you can help support our quality journalism while enjoying The Times of Israel AD-FREE, as well as accessing exclusive content available only to Times of Israel Community members.
Thank you,
David Horovitz, Founding Editor of The Times of Israel
Join Our Community
Join Our Community
Already a member? Sign in to stop seeing this
From the Liveblog of
Monday, February 8, 2021
